FAQ: Immune Cell Surface Sugars and Psoriasis Progression
TL;DR
Researchers discovered immune cells shed surface sugars before entering psoriasis-affected skin, potentially giving biotech firms like Soligenix Inc. an edge in developing targeted treatments.
Immune cells shed surface sugars prior to entering inflamed skin in psoriasis patients, revealing a key mechanism in disease progression that informs therapeutic approaches.
Understanding how immune cells shed sugars in psoriasis could lead to better treatments, improving quality of life for millions suffering from this chronic skin condition.
Scientists found immune cells literally shed their sugary coating before attacking skin in psoriasis, revealing a fascinating biological process behind this common condition.
Found this article helpful?
Share it with your network and spread the knowledge!
The study found that immune cells shed the sugars on their surface prior to entering inflamed skin in people suffering from psoriasis.
These findings could lay the foundation for understanding how psoriasis progresses and provide groundwork for new approaches to treating the disease.
Immune cells shed their surface sugars before entering the inflamed skin, which appears to be linked to the progression of psoriasis.
Research teams at entities like Soligenix Inc. (NASDAQ: SNGX) are engaged in R&D work related to bringing new treatments to market.
More information is available through BioMedWire, which specializes in biotechnology and biomedical sciences communications.
BioMedWire is a specialized communications platform focused on biotechnology and biomedical sciences that provides wire solutions, editorial syndication, press release enhancement, social media distribution, and corporate communications solutions.
You can receive SMS alerts from BioMedWire by texting 'Biotech' to 888-902-4192 (U.S. Mobile Phones Only) or visit their website at https://www.BioMedWire.com.
The content is published by BioMedWire, which is powered by IBN and part of their Dynamic Brand Portfolio with access to over 5,000 syndication outlets.
Curated from InvestorBrandNetwork (IBN)
